Antidote

MAY 4, 2022

In each episode, Rich welcomes a new guest from an organization with which Antidote is working, and takes an in-depth look at particular therapeutic areas, zeroing in on the story that Antidote's data is telling about how best to connect patients and research.

Allergies 52

Allergies Pharmacy Research 52

BioTech 365

OCTOBER 11, 2021

Sarepta Therapeutics’ SRP-9001 Shows Sustained Functional Improvements in Multiple Studies of Patients with Duchenne Sarepta Therapeutics’ SRP-9001 Shows Sustained Functional Improvements in Multiple Studies of Patients with Duchenne Results presented at ‘Micro-dystrophin Day’ highlight breadth, depth and strength of the … Continue reading → (..)

40

40

BioTech 365

FEBRUARY 18, 2021

TransCode Therapeutics Announces Key Appointments TransCode Therapeutics Announces Key Appointments Industry Experts Provide Added Depth to Board of Directors and Advisory Board BOSTON–(BUSINESS WIRE)–TransCode Therapeutics today announced that it has recently elected a Chairman of its Board of Directors, appointed … Continue reading (..)

40

40

pharmaphorum

APRIL 25, 2022

This forum will unite the exclusive community advancing the production of high-quality and consistent iPSC products, with in depth case studies aimed to develop optimal differentiation, cryopreservation, and analytical protocol to enhance process development to ensure it is robust, rapid and repeatable. Hear from: Fate Therapeutics.

Manufacturing 52

Manufacturing Gene Editing Branding Production 52

Worldwide Clinical Trials

APRIL 3, 2024

Adopting a few approaches to your study design allows you to save on resources and make more confident decisions about treatment efficacy, setting your potential therapeutic up for quicker development. Beyond protocols, it is essential to include standardized in-depth training and maintain current certification for imaging staff.

Trials 183

Trials Clinical Trials Clinical Trials Compliance 183

Pharmaceutical Technology

DECEMBER 9, 2022

Research and development highlights from the research period include the company’s work with Mirati Therapeutics in developing methods to determine torsion rotational energy barriers of the clinical compound, MRTX1719, which is being developed for use as an inhibiter to MTAP-deleted cancers. Biopharmaceutical analytical services. Switzerland.

Development 130

Development Manufacturing Production Vaccination 130

Pharmaceutical Technology

JUNE 9, 2023

Astellas Pharma (Astellas) has entered an exclusive licence deal with Kate Therapeutics (KateTx) to develop and commercialise KT430. KateTx will receive an undisclosed upfront payment from Astellas for an exclusive global licence to develop, manufacture and commercialise KT430.

Gene Therapy 147

Gene Therapy Gene Development Medicine 147

BioTech 365

SEPTEMBER 14, 2020

Lee Rauch appointed President and CEO, following resignation by William Marshall miRagen will undertake an in-depth review of its portfolio Ladenburg Thalmann engaged as financial advisor BOULDER, Colo., 14, 2020 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. NASDAQ: MGEN), a … Continue reading →

40

40

Pharmaceutical Technology

APRIL 25, 2023

The company stated that a European QP has completed an in-depth audit at its manufacturing facility in Columbus, Ohio, US. Forge Biologics has received a qualified person (QP) declaration to manufacture adeno-associated virus (AAV) gene therapies to support European clinical programmes.

Gene Therapy 130

Gene Therapy Gene Manufacturing Production 130

Drug Discovery World

MARCH 3, 2023

The international alliance will focus on leveraging the complementary capabilities, platforms and technologies from both partners, to accelerate oncology pipeline assets across a range of developmental stages and therapeutic modalities. With the breadth and depth of the combined competencies in translating research into impactful therapeutic solutions, (..)

Drugs 52

Drugs Research Development 52

Drug Discovery World

MARCH 17, 2023

The unique monocyte signatures defining subgroups of Long Covid patients reveal new pathways that could targeted for novel therapeutic opportunities in Long Covid patients. A different migration profile alongside changes to other functions correspond to fatigue.

Immune Response 52

Immune Response Drugs Vaccination Vaccine 52

Pharmaceutical Technology

JUNE 29, 2022

Based on Pharmaceutical Technology’s analysis, between 1983 and 2000, only 568 drugs received their first orphan drug designation for a specific therapeutic indication. During 2001–10, the number of granted designations almost tripled, with 1,527 drugs receiving their first orphan drug designation. Approximately 10.9% Approximately 10.9%

Drugs 246

Drugs FDA Approval Marketing Development 246

pharmaphorum

SEPTEMBER 30, 2020

The exosome therapeutics field is booming with anticipation as preparations are underway for the first few clinical trials and money pours in through partnerships and pipeline acquisitions. Uniting trailblazing teams to advance exosome therapeutics into a clinical and commercial reality. Why Should You Attend?

Development 52

Development Clinical Trials Clinical Trials Manufacturing 52

Drug Discovery World

OCTOBER 4, 2022

Life science company ValiRx has appointed Dr Cathy Tralau-Stewart as its interim Chief Scientific Officer (CSO) to help bolster its drug discovery and therapeutic expertise. ValiRx is focused on early-stage cancer therapeutics and women’s health. .

Drugs 52

Drugs Life Science Development Medicine 52

Delveinsight

SEPTEMBER 15, 2021

Oncology is one of the most competitive healthcare domains as several key players at the global level are involved in R&D activities to provide an effective therapeutic option for the people affected with different cancer. It covers the in-depth analysis of epidemiology as well as the emerging therapies in the market.

Marketing 52

Marketing Generic Drugs Development Drugs 52

Roots Analysis

JANUARY 21, 2024

With fourteen approved drugs and several drug candidates being evaluated under different stages of development, antibody drug conjugates (ADCs) are now recognized as a potent class of targeted therapeutics. Over time, a variety of other conjugated therapeutics have also been developed and are under evaluation.

Antibody 40

Antibody Recombinant DNA Technology Drugs Marketing 40

Delveinsight

SEPTEMBER 15, 2021

The Drug/Pipeline Insight report provides comprehensive insights about the companies and pipeline therapies in the therapeutics landscape. DelveInsight’s Oncology Based Diagnostics Report delivers an in-depth understanding of the historical and forecasted market trends for the diagnostic device. Epidemiology Report. Diagnostics Report.

Marketing 52

Marketing Research Production Drugs 52

Drug Discovery World

JANUARY 9, 2024

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. The therapy has shown positive results in Phase III trials in both breast and lung cancer.

Drugs 69

Drugs Gene Editing Antibody Medicine 69

Drug Channels

JUNE 13, 2022

This event showcases novel case studies and in-depth sessions that focus on innovative partnership models that will aid in delivering enhanced value, manageable costs and high-quality results. Visit www.informaconnect.com/IDN for further details and to register.

Pharmacy 69

Pharmacy Drugs Medicine 69

The Pharma Data

JANUARY 4, 2021

An experienced financial analyst and biotech executive, Dr. Farmer joins PureTech from BMO Capital Markets where he completed a 15-year career as a senior biotechnology equity analyst providing in-depth sector research for institutional investor clients. Photo: Business Wire). “We in Biological Sciences from Columbia University and a B.A.

Development 52

Development Marketing Production Medicine 52

Drug Channels

OCTOBER 5, 2020

Strategies for Field Team Compliance and Virtual Monitoring Choose from Two In-Depth Tracks and Interactive Roundtables on: Legal and Compliance Innovation and Operations Critical Insights on Overcoming the Challenges and Complexities Amid a Shifting Industry from: Evan Panich, Assistant United States Attorney , U.S. Register today.

Compliance 52

Compliance Drugs Medicine Production 52

XTalks

MARCH 7, 2024

Experts discuss the therapeutic landscape, treatment gaps, regulatory considerations and clinical trial strategies. The session covers various conditions, such as perinatal insomnia, mood disorders, anxiety and postpartum psychosis, alongside treatments ranging from psychotropics and specialized therapies to digital therapeutics.

Hormones 115

Hormones Genetics Genome Genomics 115

The Pharma Data

JANUARY 24, 2021

25, 2021 /PRNewswire/ — Notch Therapeutics Inc., Senior Vice President, Preclinical & Translational Sciences Chris Bond joins Notch with more than 18 years of experience working with biotechnology and pharmaceutical companies including Genentech, OncoMed, Juno Therapeutics, Celgene, and Kite. .

Engineer 52

Engineer Gene Editing Genome Genomics 52

Drug Discovery World

AUGUST 1, 2023

The NIH states: “This natural mechanism for sequence-specific gene silencing promises to revolutionise experimental biology and may have important practical applications in functional genomics, therapeutic intervention, agriculture and other areas.” There are many examples of ways in which RNAi is impacting drug discovery.

RNA 52

RNA Drugs Gene Silencing Vaccination 52

Drug Discovery World

JUNE 12, 2023

Not all collectors have the depth of expertise to support such a request. Our 50-year history of collecting blood and tissue products allows us to serve therapeutic development partners well.” The post ISCT 2023 key trends: the importance of cell collections appeared first on Drug Discovery World (DDW).

Gene Therapy 52

Gene Therapy Manufacturing Gene Development 52

Cloudbyz

FEBRUARY 29, 2024

As a result, pharmacovigilance teams can allocate resources more efficiently, focusing on in-depth analysis and decision-making tasks rather than routine data entry tasks.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Compliance 59

Drug Discovery World

NOVEMBER 7, 2022

EP : The Psychiatry Consortium, launched in 2019, is a strategic collaboration of leading medical research charities and pharmaceutical companies focusing on the challenge of identifying and validating novel drug targets to address the unmet therapeutic needs of people living with mental health conditions. .

Packaging 52

Packaging Packaging Drugs Clinical Trials 52

Cloudbyz

FEBRUARY 29, 2024

As a result, pharmacovigilance teams can allocate resources more efficiently, focusing on in-depth analysis and decision-making tasks rather than routine data entry tasks.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Compliance 52

Roots Analysis

JANUARY 18, 2024

Plasma fractionation, a critical process in the field of medical science, involves the separation of various components present in blood plasma to create valuable therapeutic products. Notably, the technology used in this process plays a pivotal role in determining the quality and efficacy of the resulting therapeutic products.

Manufacturing 40

Manufacturing Marketing Production Protein 40

Drug Discovery World

JULY 3, 2023

Dr Agapitos Patakas, CSO, Research & Development, Antibody Analytics, presented in this track on a customisable cell line platform for in vitro assessment of safety and efficacy of immune cell-directed therapies. This included broad antigen recognition, multivalent responses and the lack of MHC restrictions.

Antibody 52

Antibody In-Vitro Engineer In-Vivo 52

The Pharma Data

JANUARY 17, 2021

The companies will evaluate ViGeneron’s proprietary, intravitreally injected vgAAV vectors for delivering a novel therapeutic protein to develop a gene therapy treatment for a highly prevalent eye disease. MUNICH, Germany, Jan. MUNICH, Germany, Jan. Financial terms of the collaboration are not disclosed. About ViGeneron.

Gene Therapy 52

Gene Therapy Gene Research Protein 52

Drug Channels

MARCH 28, 2022

The Medicaid & GP Congress features coverage on the hottest topics impacting you today, from speakers representing United Therapeutics, AstraZeneca, Pfizer, Gilead, GSK, Eisai, Novartis, Vertex and more! Both the in-person and virtual options will include networking opportunities to connect with industry peers and colleagues.

Drugs 66

Drugs Production 66

Drug Discovery World

JANUARY 20, 2024

The most obvious display of innovation is on our exhibition floor of 90,000 square feet, but our exhibitors don’t stop there! Across the event, SLAS is turning its attention to sustainability.

Life Science 52

Life Science Research Protein Marketing 52

pharmaphorum

AUGUST 31, 2021

Secondly, within a fast-changing environment, one should focus on increasing strategic depth and reach outside of the more traditional stakeholders.

Production 63

Production Development Drugs Research 63

Camargo

OCTOBER 15, 2020

Often, to gain clinical trial design insights, a sponsor reviews the physician package inserts from approved New Drug Applications (NDAs) and Biologics License Applications (BLAs) with similar indications or in the same therapeutic area. Oncology therapeutic products are good examples of where these A&WC conditions can be met.

Production 190

Production Trials Development Clinical Trials 190

The Pharma Data

NOVEMBER 1, 2020

CAMBRIDGE, England–( BUSINESS WIRE )– Mission Therapeutics (“Mission”), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), has appointed Dr Suhail Nurbhai as Chief Medical Officer (CMO) with immediate effect. – ENDS – NOTES TO EDITORS: About Mission Therapeutics.

Clinical Research 52

Clinical Research Medicine Development Research 52

Drug Discovery World

JULY 5, 2023

Precision oncology supports targeted therapeutic treatments by determining the specific molecular characteristics of a tumour – the molecular phenotype, as it’s called – to obtain an in depth understanding of the patient’s unique cancer and using it to specifically target the patient’s cancer on a molecular level.

Research 98

Research Protein Scientist Immune Response 98